Prostaglandin E synthase 3 (cytosolic) pseudogene 4 (PTGES3P4)

PTGES3P4 stands for prostaglandin E synthase 3 (cytosolic) pseudogene 4, and is annotated as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they are generally not transcribed or translated into functional proteins[2]. Unlike its functional counterpart PTGES3 (also known as p23, a co-chaperone involved in Hsp90-mediated protein folding and certain cancer pathways[1]), PTGES3P4 does not encode a protein, and there is no evidence it acts as a direct therapeutic target, receptor, or enzyme. Most pseudogenes, including PTGES3P4, have no direct enzymatic, signaling, or receptor functions, and there are no reports of drug interactions or use as a biomarker for this pseudogene. The assignment of this sequence as a "target" is therefore incorrect. Summary of errors/limitations: - PTGES3P4 is not a functional protein, enzyme, receptor, or known drug target. - It is possible, in rare instances, for some pseudogenes to be transcribed or have indirect regulatory roles, but there is no evidence of such a role for PTGES3P4[2]. - Confusion may arise because PTGES3 (not PTGES3P4) is an active protein and established research target in oncology and immunity[1]. Key distinction: - PTGES3 (also called p23, cytosolic prostaglandin E synthase 3) is a functional chaperone protein with roles in cancer and immunity.[1] - PTGES3P4 is a pseudogene and not a functional target[2]. *If you need detailed information for the gene PTGES3 (not PTGES3P4), please clarify.*

Other names

Prostaglandin E synthase 3 pseudogene 4PTGES3P4

None known